Bristol-Myers (NYSE:BMY) was downgraded to neutral by Bank of America/Merrill Lynch (NYSE:BAC) as the fundamentals do not justify a higher stock price though the yield is attractive. A $39 price target was issued.
Shares are lower by about seven tenths of a percent.
Micron (NASDAQ:MU) was downgraded by Lazard Capital Markets (NYSE:LAZ) to neutral due to reduced demand DRAM deman projections in the coming months.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.